Whilst bariatric surgeries and recent generations of incretin mimetics offer significant advances in anti-obesity therapies [1, 2], dietary modification remains an integral component of effective obesity treatment paradigms. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.